DiscoverNETWiseNETWise Episode 45: Managing the Financial Burden of Neuroendocrine Cancer
NETWise Episode 45: Managing the Financial Burden of Neuroendocrine Cancer

NETWise Episode 45: Managing the Financial Burden of Neuroendocrine Cancer

Update: 2025-04-21
Share

Description


















This episode is part of a collaboration with the FlaNET Carcinoid Community, focusing on financial toxicity. We explore some of the major costs that can arise throughout the neuroendocrine cancer journey and share guidance on how to find helpful resources.











NET specialists included in this episode

Use our episode infographics to get a visual picture of some of the things we have discussed.










Joanna Doran, JD, is the CEO of Triage Cancer, a national nonprofit that provides free education on legal issues that may impact people diagnosed with cancer.














Mysti Motz, BNS, RN, is a nurse who previously worked at the University of Miami’s Sylvester Comprehensive Cancer Center, where she provided care and support to patients in the Neuroendocrine Cancer Program.














Samantha Powell, LCSW, is a social worker licensed in Utah and Iowa who has worked with neuroendocrine cancer patients.














Sasha Watson, Pharm.D.,is a clinical pharmacist at the University of Miami Sylvester Comprehensive Cancer Center.















Thank you to Matt Skinner for sharing his neuroendocrine cancer journey.

Additional Resources:









Thank you to Triage Cancer for sharing the following resources:

Practical Guide to Cancer Rights: https://triagecancer.org/guide

Cancer Finances: https://triagecancer.org/cancer-finances

Free medical flights:
https://www.angelflight.com/
<a href="https://angelflightwe

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NETWise Episode 45: Managing the Financial Burden of Neuroendocrine Cancer

NETWise Episode 45: Managing the Financial Burden of Neuroendocrine Cancer

Neuroendocrine Tumor Research Foundation (NETRF)